Cite Filings / RYTM / 0001950047-25-000729
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

RHYTHM PHARMACEUTICALS, INC. · Filed 2025-02-10 · Acc 0001950047-25-000729

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2025-02-12 144 Sale of Securities
  • 2025-02-11 4 EVP, Head of North America sold 5,216 shares at an average $58.64 ($305,846)
  • 2025-02-11 4 Chief Human Resources Officer sold 701 shares at an average $57.51 ($40,315)
  • 2025-02-11 4 Chief Financial Officer sold 1,296 shares at an average $57.51 ($74,533)
  • 2025-02-10 144 Sale of Securities
  • 2025-02-10 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-05 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…